BRANMOOR
THURSDAY · 14 MAY 2026

FDA Recall D-0250-2022

Bayer Healthcare Pharmaceuticals Inc. · Whippany, NJ

Class I — life-threatening Terminated 633 days on record

Highest impact — Class I recall — FDA determination of strong likelihood of serious adverse health consequence or death.

Product

Tinactin (Tolnaftate 1%) DEODORANT POWDER SPRAY NET WT 133g (4.6 OZ) can, Dist by: Bayer Healthcare LLC, Whippany, NJ 07981, UPC 3 11017 41000 4, NDC 11523-4162-1, Product of Finland 20006105

Lot / code: Lot # TN0067A, EXP 2/28/2023; TN008CU, EXP 4/30/2023;

Quantity: 738,432 cans

Reason for recall

Chemical Contamination: presence of benzene

Recall record

Recall number
D-0250-2022
Classification
Class I
Status
Terminated
Voluntary or mandated
Voluntary: Firm initiated
Firm notification
Press Release
Distribution
Distributed Nationwide in the US, Puerto Rico, Canada and Mexico through a variety of retail channels.
Recall initiated
2021-10-01
Classified by FDA Center
2021-11-18
FDA published
2021-11-24
Terminated
2023-06-26
Recalling firm
Bayer Healthcare Pharmaceuticals Inc.
Firm location
Whippany, NJ

Drug identification

Brand name(s)
TINACTIN
Generic name(s)
TOLNAFTATE
Manufacturer(s)
Bayer HealthCare LLC.
NDC(s)
11523-4162
Route(s)
TOPICAL

‹ All recalls